Explore intersection genes of oxymatrine and COVID-19 with lung cancer as potential therapeutic targets based on network pharmacology
Conclusion. To treat COVID-19 or lung cancer paired with COVID-19, oxymatrine may improve the therapeutic efficacy of current clinical antiviral medicines and immunotherapy.PMID:37855710 | DOI:10.1099/jmm.0.001766
Source: Journal of Medical Microbiology - Category: Microbiology Authors: Wei Wu Chuan Cheng Dongdong Yuan Li Peng Le Li Source Type: research
More News: Cancer | Cancer & Oncology | COVID-19 | Databases & Libraries | Drugs & Pharmacology | Genetics | Immunotherapy | Lung Cancer | Microbiology | Study | Switzerland Health | Websites